Initial vancomycin versus metronidazole for the treatment of first-episode non-severe Clostridioides difficile infection
Abstract Objective: Clostridioides difficile infection (CDI) is the leading cause of infectious nosocomial diarrhea. Although initial fidaxomicin or vancomycin treatment is recommended by most major guidelines to treat severe CDI, there exists varied recommendations for first-episode non-severe CDI....
Saved in:
Main Authors: | Kevin Zhang (Author), Patricia Beckett (Author), Salaheddin Abouanaser (Author), Marek Smieja (Author) |
---|---|
Format: | Book |
Published: |
Cambridge University Press,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-World Budget Impact of Fidaxomicin versus Vancomycin or Metronidazole for In-Hospital Treatment of <i>Clostridioides difficile</i> Infection
by: Laura Whitney, et al.
Published: (2023) -
Effective Dosage of Oral Vancomycin in Treatment for Initial Episode of <i>Clostridioides difficile</i> Infection: A Systematic Review and Meta-Analysis
by: Chia-Yu Chiu, et al.
Published: (2019) -
Comparison of fidaxomicin to oral vancomycin for the treatment of Clostridioides difficile infection in hospitalized patients
by: A. Krishna Rao, et al.
Published: (2022) -
Utilizing vancomycin as secondary prophylaxis for the prevention of recurrent Clostridioides difficile infection
by: Zeitler Kristen, et al.
Published: (2023) -
Genetic Mechanisms of Vancomycin Resistance in <i>Clostridioides difficile</i>: A Systematic Review
by: Taryn A. Eubank, et al.
Published: (2022)